Allergy Diagnostics Market,by Product & Service Type (Consumables, Instruments [Immunoassay Analyzers, Elisa Analyzers, Luminometers, and Other Instruments], and Services), Test Type (In Vivo Tests [Skin Prick Tests, Patch Tests, and Other In Vivo Tests] and In Vitro Tests), Allergen Type (Inhaled Allergens, Food Allergens, Drug Allergens, and Other Allergens), End-User Type (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, and Other End-Users), and Region (North America, Europe, Asia-Pacific, and Rest of the World).
Allergy Diagnostics Market, by Product & Service Type (Consumables, Instruments [Immunoassay Analyzers, Elisa Analyzers, Luminometers, and Other Instruments], and Services), Test Type (In Vivo Tests [Skin Prick Tests, Patch Tests, and Other In Vivo Tests] and In Vitro Tests), Allergen Type...
"The global allergy diagnostics market was estimated to grow from USD 4.96 billion in 2021 to USD 10.33 billion by 2028 at a healthy CAGR of 10.94% during the forecast period of 2022-2028."
Allergy diagnostics are performed to identify allergens like mold, bee stings, and peanuts, and pet dander, which can cause allergies. An allergy is an immune system hypersensitivity disorder. Allergic reactions occur when a person's immune system reacts to harmless substances in the environment known as allergens.
Allergy Diagnostics Market Report Overview
Market Size in 2021
US$ 4.96 Billion
Market Size in 2028
US$ 10.33 Billion
CAGR (2022-2028)
10.94%
Base Year of Study
2021
Trend Period
2016-2020
Forecast Period
2022-2028
Dominant Region
The North American region accounted for the fastest-growing market share during the forecast period.
The global allergy diagnostics market is driven by several factors, including:
Rising prevalence of allergic diseases: Allergies are among the most common diseases, affecting around 1 in 5 people. Allergies like Asthma, food allergies, etc. are growing rapidly. According to various sources, more than 330 million people are suffering from Asthma, and 2,50,000 deaths are attributed to this each year. The estimates show that 100 million new asthma cases may be detected. This growing prevalence of different allergies heightens the demand for allergy diagnostics market.
Growing levels of environmental pollution: Air pollution remains one of the most common causes of allergies across the globe. Data from the World Health Organization shows that 9 out of 10 people inhale air containing high levels of pollution. This gives rise to different allergies and creates a need for diagnosis.
Increasing adoption of IVD techniques: In vitro diagnostics (IVD) techniques are gaining traction significantly propelling the allergy diagnostics market. IVD techniques are used to diagnose diseases and other conditions by analyzing samples of blood, urine, tissue, and other bodily fluids. Technological advancements: With the growing need for allergy diagnosis, more accurate, and less invasive methods of diagnosis are being developed. For instance, in June 2023, researchers from the Biological Science Research division at Kao Corporation developed a breakthrough ‘RNA monitoring’ method to diagnose early-onset atopic dermatitis in infants using sebum.
"The consumables segment accounted for the largest market share."
The market is segmented into consumables, instruments, and services. The consumables segment is expected to capture a major share of the global market during the forecast period. The growing prevalence of allergies and the need for rapid tests to diagnose allergic conditions can be attributed to the dominance of the consumables segment.
Instruments accounted for the second-largest share of the global allergy diagnostics market in 2021, due to the introduction of technologically advanced products with improved accuracy and throughput. Increasing laboratory automation and healthcare improvements are expected to provide lucrative growth opportunities for this market.
Companies' growing focus on R&D to develop novel diagnostic equipment, tests, and kits to address unmet medical needs has a significant impact on market growth.
Test Insights
"In Vivo Testssegment accounted for the largest market share."
The market is segmented into in vivo tests and in vitro tests. In Vivo Tests are estimated to hold the major share of the market during the forecast period. The growing demand for efficient, rapid, and simple testing options has fueled the growth of in vivo diagnostic tests, which measure the reactivity and susceptibility of dermal mast cells to indicate allergic sensitivity. These procedures involve skin exams with standardized allergenic extracts to ensure reliability.
The in vitro tests segment is expected to grow significantly over the forecast period, as these tests are used to identify allergen-specific immunoglobulin E (IgE). Radioallergosorbent testing (RAST) is an in vitro method for detecting allergen-specific antibodies of a new immunoglobulin class called immunoglobulin D (IgD). The increasing prevalence of various allergic diseases is driving demand for early detection and diagnosis of allergens, which is expected to propel the market growth for efficient diagnostic tests and systems.
End-User Insights
"Diagnostic laboratoriessegment accounted for the largest market share."
The market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end-users. Diagnostic laboratories are estimated to hold the major share of the global market during the forecast period. The diagnostic Laboratories segment is driven by the growing awareness among consumers regarding the management of allergic diseases, preference for proper diagnosis from specialists, and the availability of funds for the operation of independent diagnostic laboratories.
Regional Trends
"North Americaaccounted for the largest market share."
North America is estimated to be the dominating region in the global market over the forecast period. The region is dominating because of favorable regulations and initiatives by associations, increasing incidences of allergies, and favorable reimbursement conditions for allergy diagnosis, all of which are fuelling regional market growth. Furthermore, Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period. The Asia Pacific region is projected to grow at the fastest CAGR over the forecast period, driven by key markets such as Japan, China, and India. Key players in these countries are undertaking various strategic initiatives to increase their dominance in the regional market.
This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.
What Deliverables Will You Get in This Report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth analysis of the allergy diagnosticsmarket.
How lucrative is the future?
The market forecast and trend data and emerging trends.
Which regions offer the best sales opportunities?
Global, regional, and country-level historical data and forecasts.
Which are the most attractive market segments?
Market Segment Analysis and Forecast.
What are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, and Life cycle analysis.
What are the factors affecting the market?
Drivers & challenges.
Will I get the information on my specific requirements?
10% free customization.
This report studies the market covering 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.
The global allergy diagnostics market is segmented into the following categories.
By Product & Service Type
Consumables
Instruments
Regional Analysis: North America, Europe, Asia-Pacific, and RoW
Type Analysis: Immunoassay Analyzers, Elisa Analyzers, Luminometers, and Other Instruments
Services
By Test Type
In Vivo Tests
Regional Analysis: North America, Europe, Asia-Pacific, and RoW
Type Analysis: Skin Prick Tests, Patch Tests, and Other In Vivo Tests
In Vitro Tests
By Allergen Type
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
By End-User Type
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Other End-Users
By Region
North America (Country: the USA, Canada, and Mexico)
Europe (Country: Germany, France, the UK, Russia, and Rest of Europe)
Asia-Pacific (Country: China, Japan, India, and Rest of Asia-Pacific)
Rest of the World (Sub-Region: Latin America, the Middle East, and Others)
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Report Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to 3 players)
SWOT analysis of key players (up to 3 players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
Allergy diagnostics are performed to identify allergens like mold, bee stings, and peanuts, pet dander, which can cause allergies. An allergy is an immune system hypersensitivity disorder. Allergic reactions occur when a person's immune system reacts to harmless substances in the environment known as allergens.
The global allergy diagnostics market is driven by several factors, including:
1. Rising prevalence of allergic diseases: Allergies are among the most common diseases, affecting around 1 in 5 people. Allergies like Asthma, food allergies, etc. are growing rapidly. According to various sources, more than 330 million people are suffering from Asthma, and 2,50,000 deaths are attributed to this each year. The estimates show that 100 million new asthma cases may be detected. This growing prevalence of different allergies heightens the demand for allergy diagnostics market.
2. Growing levels of environmental pollution – Air pollution remains one of the most common causes of allergies across the globe. Data from the World Health Organization shows that 9 out of 10 people inhale air containing high levels of pollution. This gives rise to different allergies and creates a need for diagnosis.
3. Increasing adoption of IVD techniques - In vitro diagnostics (IVD) techniques are gaining traction significantly propelling the allergy diagnostics market. IVD techniques are used to diagnose diseases and other conditions by analyzing samples of blood, urine, tissue, and other bodily fluids.
4. Technological advancements – With the growing need for allergy diagnosis, more accurate, and less invasive methods of diagnosis are being developed. For instance, in June 2023, researchers from the Biological Science Research division at Kao Corporation developed a breakthrough ‘RNA monitoring’ method to diagnose early-onset atopic dermatitis in infants using sebum.